Zu "571170-77-9" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Laropiprant
Artikelnummer: TGM-T15712-100mg
Description: Laropiprant (MK-0524) is a potent and selective antagonist of prostaglandin D2 (PGD2) receptor (DP) such as and DP/DP1 receptor(Ki = 0.57 nM) and TP Receptor(Ki = 2.95 nM). Target: Prostaglandin Receptor. Smiles: CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12. References: Sturino CF, et al....
| Schlagworte: | MK-0524 |
| Anwendung: | Targets prostaglandin D2 receptor (PTGDR) |
| CAS | 571170-77-9 |
| MW: | 435.9 D |
ab 33,00 €
MK-0524
Artikelnummer: Cay10009835-5
MK-0524 is a potent, selective prostaglandin D2 (PGD2) receptor DP1 antagonist with Ki values of 0.57 nM and 0.75 µM for the DP1 and DP2 receptors, respectively. It inhibits PGD2-induced accumulation of cAMP in both washed platelets and platelet-rich plasma with IC50 values of 0.09 and 4.0 nM, respectively. In a...
| Schlagworte: | Laropiprant, (3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-cyclopent[b]indole-3-acetic acid |
| Anwendung: | DP1 receptor antagonist |
| CAS | 571170-77-9 |
| MW: | 435.9 D |
ab 78,00 €
MK-0524
Artikelnummer: LKT-M4100.1
MK-0524 is a specific prostaglandin D2 receptor (DP1) inhibitor that functions as an inverse agonist. MK-0524 decreases niacin-induced flushing during niacin treatment of dyslipidemia and is most often studied in combination with niacin. The ability of MK-0524 to inhibit DP1 prevents PGD2-induced hyaluron synthesis,...
| Schlagworte: | Laropiprant |
| Anwendung: | Prostaglandin D2 receptor antagonist |
| CAS | 571170-77-9 |
| MW: | 435.9 D |
ab 95,00 €
